The Journey of #GoLongOnHealth Starts Here.
Our non-invasive, real-time technologies enhance care through early detection, continuous monitoring, and long-term support for measurable, actionable, and sustainable health.
Our non-invasive, real-time technologies enhance care through early detection, continuous monitoring, and long-term support for measurable, actionable, and sustainable health.
At Aarca Research, every solution is developed through an iterative process that ensures safety, quality, and clinical relevance. By combining engineering expertise, clinical insight, and regulatory rigor, we deliver solutions that strengthen the continuum of care and help patients and providers #GoLongOnHealth.
All solutions are developed under our ISO 13485:2016 compliant quality management system and aligned with CDSCO and international regulatory standards. This ensures compliance, safety, and readiness for global markets.
We begin by identifying pressing healthcare challenges and designing solutions that create measurable impact. Prototypes are developed with usability, accuracy, and clinical workflows in mind.
Every solution undergoes extensive bench testing and structured clinical trials. Validation covers safety, performance, and repeatability to ensure reliability in real-world settings.
Following regulatory clearance, we launch with a commitment to continuous improvement. Post-market feedback, updates, and user training ensure that our solutions evolve with healthcare needs and continue to deliver measurable impact.
Our multidisciplinary teams integrate advanced sensor fusion, AI, and data science with robust engineering methods. We use an agile, user-centric approach to ensure each solution is both technically sound and practical in the field.
At Aarca Research, we design and deliver innovative health screening and diagnostic solutions that empower organizations to detect risks early, make data-driven decisions, and improve overall wellness outcomes.
#GoLongOnMetabolicHealth
IHRA uses thermal imaging enhanced by AI and computer vision to identify early patterns of Type 2 Diabetes, Hypertension, and Dyslipidemia — providing rapid, non-invasive risk assessments for earlier action.
#GoLongOnHealthInsights
Hayl is a handheld device that provides over 40 metabolic and cardiovascular indicators in one minute. Designed for accessibility and speed, it supports routine screening, preventive programs, and ongoing monitoring.
#GoLongOnVascularHealth
PVHP is a structured peripheral vascular screening program designed to identify early signs of vascular compromise and limb health risk. By standardizing multi-parameter screening, it enables timely clinical referral and preventive intervention.
#GoLongOnVascularHealth
NerveVue is a screening and diagnostic tool for non-invasive assessment of Peripheral Artery Disease (PAD). By detecting circulation issues early, it enables timely referrals and interventions that prevent serious complications.
